Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rosseti Siberia reported for 9 months of 2023 by IFRS

11/24/23 MRKS

Board of Directors of Novorossiysk Bakery Products Plant recommended dividends

11/24/23 NKHP

Bank Saint Petersburg updated its development strategy

11/24/23 BSPB

Lenta opened Monetka stores in Moscow and St. Petersburg

11/24/23 LENT

Rosseti North-West reported for 9 months of 2023 by IFRS

11/24/23 MRKZ

VTB reported for 10 months of 2023 by IFRS

11/24/23 VTBR

Yandex began to develop the vertical of urgent delivery of goods

11/24/23 YNDX

Bank Saint-Petersburg reported for 9 months of 2023 by IFRS

11/24/23 BSPB

Rosseti Urals reported for 9 months of 2023 by IFRS

11/24/23 MRKU

Positive Technologies to start selling overseas in 2024

11/24/23 POSI